
Canadian Journal of General Internal Medicine
26 Volume 13, Special Issue 1, 2018
6. Parkash R, Maisel WH, Toca FM, Stevenson WG. Atrial fibrillation in heart
failure: high mortality risk even if ventricular function is preserved. AmHeart
J 2005;150:701–706.
7.
Kirchhof P, Schmalowsky J, Pittrow D et al. Management of patients with
atrial fibrillation by primary-care physicians in Germany: 1-year results of
the ATRIUM registry. Clin Cardiol 2014;37:277–84.
8.
Wolf PA, Mitchell JB, Baker CS, Kannel WB, D’Agostino RB. Impact of
atrial fibrillation on mortality, stroke, and medical costs. Arch Intern Med
1998;158:229–34.
9.
McDonald AJ, Pelletier AJ, Ellinor PT, Camargo CA, Jr. Increasing US
emergency department visit rates and subsequent hospital admissions for
atrial fibrillation from 1993 to 2004. AnnEmergMed 2008;51:58–65.
10.
Khaykin Y, Morillo CA, Skanes AC, McCracken A, Humphries K, Kerr
CR. Cost comparison of catheter ablation and medical therapy in atrial
fibrillation. Journal of cardiovascular electrophysiology 2007;18:907–13.
11.
Gladstone DJ, Bui E, Fang J et al. Potentially preventable strokes in high-risk
patients with atrial fibrillation who are not adequately anticoagulated. Stroke
2009;40:235–240.
12.
Ogilvie IM, Newton N, Welner SA, Cowell W, Lip GY. Underuse of
oral anticoagulants in atrial fibrillation: a systematic review. Am J Med
2010;123:638–645.
13.
Nattel S. New ideas about atrial fibrillation 50 years on. Nature 2002;415:219–226.
14.
Haissaguerre M, Jais P, Shah DC et al. Spontaneous initiation of atrial
fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med
1998;339:659–666.
15.
Dixit S, Marchlinski FE, Lin D et al. Randomized ablation strategies for
the treatment of persistent atrial fibrillation: RASTA study. Circ Arrhythm
Electrophysiol 2012;5:287–94.
16.
Saygili E, Rana OR, Saygili E et al. Losartan prevents stretch-induced
electrical remodeling in cultured atrial neonatal myocytes. Am J Physiol
Heart Circ Physiol 2007;292:H2898-H2905.
17.
Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation
begets atrial fibrillation. A study in awake chronically instrumented goats.
Circulation 1995;92:1954–1968.
18.
Scherlag BJ, Patterson E, Po SS. The neural basis of atrial fibrillation. J
Electrocardiol 2006.
19. Kistler PM, Sanders P, Dodic M et al. Atrial electrical and structural
abnormalities in an ovine model of chronic blood pressure elevation after
prenatal corticosteroid exposure: implications for development of atrial
fibrillation. Eur Heart J 2006;27:3045–3056.
20. Anter E, Di Biase L, Contreras-Valdes FM et al. Atrial Substrate and Triggers
of Paroxysmal Atrial Fibrillation in Patients With Obstructive Sleep Apnea.
Circ Arrhythm Electrophysiol 2017;10.
21.
Gillis AM, Verma A, Talajic M, Nattel S, Dorian P. Canadian cardiovascular
society atrial fibrillation guidelines 2010: rate and rhythm management.
CanJCardiol 2011;27:47–59.
22.
Cairns JA, Connolly S, McMurtry S, Stephenson M, Talajic M. Canadian
cardiovascular society atrial fibrillation guidelines 2010: prevention of stroke
and systemic thromboembolism in atrial fibrillation and flutter. CanJCardiol
2011;27:74–90.
23. Healey JS, Parkash R, Pollak PT, Tsang TS, Dorian P. Canadian
Cardiovascular Society 2010 Atrial Fibrillation Guidelines: Chapter 2 - Atrial
Fibrillation: Etiology and Initial Investigations. CanJCardiol 2011.
24.
Wyse DG, Van Gelder IC, Ellinor PT et al. Lone atrial fibrillation: does it
exist? J Am Coll Cardiol 2014;63:1715–23.
25. Schnabel RB, Yin X, Gona P et al. 50 year trends in atrial fibrillation
prevalence, incidence, risk factors, and mortality in the Framingham Heart
Study: a cohort study. Lancet 2015;386:154–62.
26. Staerk L, Wang B, Preis SR et al. Lifetime risk of atrial fibrillation according
to optimal, borderline, or elevated levels of risk factors: cohort study based on
longitudinal data from the Framingham Heart Study. BMJ 2018;361:k1453.
27. Van Wagoner DR, Piccini JP, Albert CM et al. Progress toward the prevention
and treatment of atrial fibrillation: A summary of the Heart Rhythm Society
Research Forum on the Treatment and Prevention of Atrial Fibrillation,
Washington, DC, December 9-10, 2013. Heart Rhythm 2015;12:e5-e29.
28.
Belardinelli R, Georgiou D, Ginzton L, Cianci G, Purcaro A. Effects of
moderate exercise training on thallium uptake and contractile response to
low-dose dobutamine of dysfunctional myocardium in patients with ischemic
cardiomyopathy. Circulation 1998;97:553–561.
29. Osbak PS, Mourier M, Kjaer A, Henriksen JH, Kofoed KF, Jensen GB. A
randomized study of the effects of exercise training on patients with atrial
fibrillation. AmHeart J 2011;162:1080–1087.
30.
Reed JL, Mark AE, Reid RD, Pipe AL. The effects of chronic exercise
training in individuals with permanent atrial fibrillation: a systematic review.
CanJCardiol 2013;29:1721–1728.
31.
Giacomantonio NB, Bredin SS, Foulds HJ, Warburton DE. A systematic
review of the health benefits of exercise rehabilitation in persons living with
atrial fibrillation. CanJCardiol 2013;29:483–491.
32.
Qureshi WT, Alirhayim Z, Blaha MJ et al. Cardiorespiratory Fitness and Risk
of Incident Atrial Fibrillation: Results From the Henry Ford Exercise Testing
(FIT) Project. Circulation 2015;131:1827–34.
33.
Pathak RK, Elliott A, Middeldorp ME et al. Impact of CARDIOrespiratory
FITness on Arrhythmia Recurrence in Obese Individuals With Atrial
Fibrillation: The CARDIO-FIT Study. J Am Coll Cardiol 2015;66:985–96.
34.
Abed HS, Wittert GA, Leong DP et al. Effect of weight reduction and
cardiometabolic risk factor management on symptom burden and severity
in patients with atrial fibrillation: a randomized clinical trial. JAMA
2013;310:2050–2060.
35. Rienstra M, Hobbelt AH, Alings M et al. Targeted therapy of underlying
conditions improves sinus rhythm maintenance in patients with persistent
atrial fibrillation: results of the RACE 3 trial. Eur Heart J 2018.
36.
Pathak RK, Middeldorp ME, Meredith M et al. Long-Term Effect of Goal
Directed Weight Management in an Atrial Fibrillation Cohort: A Long-term
Follow-Up StudY (LEGACY Study). J Am Coll Cardiol 2015.
37.
Parkash R, Verma A, Tang AS. Persistent atrial fibrillation: current approach
and controversies. Curr Opin Cardiol 2010;25:1–7.
38. Healey JS, Connolly SJ. Atrial fibrillation: hypertension as a causative agent,
risk factor for complications, and potential therapeutic target. Am J Cardiol
2003;91:9G-14G.
39.
Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis,
and predisposing conditions for atrial fibrillation: population-based
estimates. Am J Cardiol 1998;82:2N-9N.
40.
Conen D, Tedrow UB, Koplan BA, Glynn RJ, Buring JE, Albert CM.
Influence of systolic and diastolic blood pressure on the risk of incident atrial
fibrillation in women. Circulation 2009;119:2146–2152.
41.
Wachtell K, Lehto M, Gerdts E et al. Angiotensin II receptor blockade reduces
new-onset atrial fibrillation and subsequent stroke compared to atenolol:
the Losartan Intervention For End Point Reduction in Hypertension (LIFE)
study. J Am Coll Cardiol 2005;45:712–719.
42. Healey JS, Baranchuk A, Crystal E et al. Prevention of atrial fibrillation with
angiotensin-converting enzyme inhibitors and angiotensin receptor blockers:
a meta-analysis. J Am Coll Cardiol 2005;45:1832–1839.
43. Disertori M, Latini R, Barlera S et al. Valsartan for prevention of recurrent
atrial fibrillation. N Engl J Med 2009;360:1606–1617.
44.
Yusuf S, Healey JS, Pogue J et al. Irbesartan in patients with atrial fibrillation.
N Engl J Med 2011;364:928–38.
45. Parkash R, Wells GA, Sapp JL et al. Effect of Aggressive Blood Pressure
Control on the Recurrence of Atrial Fibrillation After Catheter Ablation:
A Randomized, Open-Label Clinical Trial (SMAC-AF [Substrate
Modification With Aggressive Blood Pressure Control]). Circulation
2017;135:1788–1798.
46. Leung AA, Daskalopoulou SS, Dasgupta K et al. Hypertension Canada’s 2017
Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of
Hypertension in Adults. Can J Cardiol 2017;33:557–576.
47. Marini C, De SF, Sacco S et al. Contribution of atrial fibrillation to incidence
and outcome of ischemic stroke: results from a population-based study.
Stroke 2005;36:1115–1119.
48. Holmqvist F, Guan N, Zhu Z et al. Impact of obstructive sleep apnea and
continuous positive airway pressure therapy on outcomes in patients with
atrial fibrillation-Results from the Outcomes Registry for Better Informed
Does Lifestyle Impact Risk, Burden, and Symptomatology of Atrial Fibrillation?